上海市闵行区不同级别医院口服降糖药的应用分析

发布时间：2018-01-15 05:02

本文关键词：上海市闵行区不同级别医院口服降糖药的应用分析　出处：《中国卫生经济》2017年09期 　论文类型：期刊论文

【摘要】：目的:分析上海市闵行区不同级别医院口服降糖药用药特点,为临床合理用药提供参考。方法:采用回顾性分析方法,对区内16家医院2015年12月—2016年11月口服降糖药用药金额、用药频度(DDDs)及日均费用(DDC)等指标进行统计分析。结果:2015年12月—2016年11月本区口服降糖药购药总金额6 751.05万元,其中一级医院占76.89%,阿卡波糖在一、二、三级医院分别排名第1。一级医院有5个品种购药金额在300~800万元之间,格列吡嗪控释片排名第2。瑞格列奈购药金额在二、三级医院排名第2。一级医院二甲双胍用药频度最高为834.02万日。DDC最高为阿卡波糖在一、二、三级医院分别排名第1,沙格列汀在二、三级医院排名第2。一、二、三级医院用药一致性为28.13%。结论:我区糖尿病患者主要在社区配药,医生和患者更趋向选择基本药物,价格合理,一、二级医院用药品规更接近。
[Abstract]:Objective: to analyze the characteristics of oral hypoglycemic drugs used in different hospitals in Minhang District of Shanghai, and to provide reference for rational use of drugs in clinic. Methods: retrospective analysis was used. The total amount of oral hypoglycemic drugs used in 16 hospitals in the region from December 2015 to November 2016 was analyzed. DDDs) and daily average cost (DDC). Results: from December 2015 to November 2016, the total purchase amount of oral hypoglycemic drugs was sixty-seven million five hundred and ten thousand and five hundred yuan. Among them, first class hospital accounted for 76.89 yuan, and acarbose ranked first, second and third respectively. There were 5 kinds of hospitals in the first class hospital with purchase amount ranging from 300 to 8 million yuan. Glipizide controlled-release tablets ranked 2nd. The amount of reaglinide purchased was in the second place, the third class hospital ranked 2nd. The highest frequency of metformin use in the first class hospital was 834.02 million days. The highest DDC was acarbose in one. The second and third level hospitals ranked first respectively, and the second and third grade hospitals ranked 2nd. First and second, the consistency of drug use was 28.130.Conclusion: diabetes patients in our district are mainly dispensed in community. Doctors and patients tend to choose essential drugs at reasonable prices.
【作者单位】：上海市闵行区古美社区卫生服务中心;上海市闵行区卫生和计划生育委员会;
【基金】：上海市闵行区科学技术委员会自然科学研究课题(2016MHZ04)
【分类号】：R95
【正文快照】： 糖尿病是以慢性高血糖为特征的一组代谢性疾病。全球糖尿病的整体发病情况呈快速上升趋势。糖尿病被世界卫生组织列为仅次于心血管疾病和癌症的第3位致死性疾病。2013年,国际糖尿病联合会发布数据表明,全球有3.82亿人患有糖尿病,且在未来25年内患病人数将超过5.92亿[1]。我国

【相似文献】